BREAKING
KVH Industries Inc (KVHI) Reports Q4 Earnings 50 minutes ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 1 hour ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 1 hour ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 2 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 2 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 2 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 2 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 3 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 3 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 4 hours ago KVH Industries Inc (KVHI) Reports Q4 Earnings 50 minutes ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 1 hour ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 1 hour ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 2 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 2 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 2 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 2 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 3 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 3 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 4 hours ago
ADVERTISEMENT
Analysis

WAY Shares Close at $24.29 After Waystar Reports Q4 2025 Results

$WAY February 17, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$WAY · Earnings

Waystar Holding Corp (Nasdaq: WAY) shares closed at $24.

Waystar Holding Corp (Nasdaq: WAY) shares closed at $24.29 at the latest U.S. market close following the company’s fourth-quarter and full-year 2025 earnings release.

Market Capitalization

Based on approximately 191.6 million shares outstanding as of December 31, 2025, Waystar’s market capitalization stands at roughly $4.65 billion.

Latest Quarterly Results

For the quarter ended December 31, 2025, Waystar reported revenue of $303.5 million, compared with $244.1 million in the fourth quarter of 2024, reflecting 24% year-over-year growth.

Net income was $20.0 million, versus $19.1 million in the prior-year period. Diluted earnings per share were $0.10, compared with $0.11 a year earlier.

Adjusted EBITDA for the quarter was $129.1 million, with an adjusted EBITDA margin of 43%.

ADVERTISEMENT

Full-Year Results Context

For fiscal year 2025, Waystar reported revenue of $1,099.3 million, compared with $943.5 million in fiscal 2024, representing 17% year-over-year growth.

Net income for fiscal 2025 was $112.1 million. Diluted earnings per share were $0.61, versus a loss per share of $0.13 in the prior year.

Adjusted EBITDA for the full year was $462.1 million, with an adjusted EBITDA margin of 42%.

Business & Operations Update

Waystar reported 1,391 clients generating more than $100,000 in last-twelve-month revenue, up 16% year over year. Net revenue retention rate was 112%.

Fourth-quarter subscription revenue totaled $167.8 million, up 38% year over year, while volume-based revenue reached $134.2 million, up 11%.

ADVERTISEMENT

The company processed over 7.5 billion healthcare payment transactions annually, spanning approximately 60% of US patients, according to company disclosures.

M&A or Strategic Moves

Cash flow statements show $629.5 million in acquisition-related cash outflows during fiscal 2025, net of cash acquired, reflecting completed transactions during the year.

Equity Analyst Commentary

Institutional coverage following the earnings release focused on subscription revenue growth, adjusted EBITDA margins, and the return to positive GAAP net income compared with the prior-year loss, based on company filings.

Guidance & Outlook

For fiscal year 2026, Waystar expects total revenue between $1.274 billion and $1.294 billion. Adjusted EBITDA is projected between $530 million and $540 million, and non-GAAP net income between $317 million and $335 million.

Performance Summary

WAY shares closed at $24.29. Fourth-quarter revenue increased 24% year over year. Net income rose modestly. Fiscal 2025 revenue grew 17%, and the company reported positive annual net income. Subscription revenue and client retention expanded. Fiscal 2026 guidance was issued.

ADVERTISEMENT
ADVERTISEMENT